| LMORX | VEXAX | LMORX / VEXAX | |
| Total Expense Ratio | 2.01 | 0.05 | 4,020% |
| Annual Report Gross Expense Ratio | 2.02 | 0.05 | 4,040% |
| Fund Existence | 19 years | 25 years | - |
| Gain YTD | 4.329 | 5.025 | 86% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.96B | 82.1B | 2% |
| Annual Yield % from dividends | 0.00 | 1.14 | - |
| Returns for 1 year | 31.50 | 15.02 | 210% |
| Returns for 3 years | 100.44 | 56.02 | 179% |
| Returns for 5 years | 15.46 | 28.45 | 54% |
| Returns for 10 years | 218.58 | 205.00 | 107% |
| 1 Day | |||
|---|---|---|---|
| STOCK / NAME | Price $ | Chg $ | Chg % |
| MAPGF | 1.13 | 0.21 | +22.83% |
| Mapletree Logistics Trust Units Real Estate Investment Trust | |||
| KSKGF | 4.04 | 0.09 | +2.17% |
| Kingsgate Consolidated Ltd. | |||
| POROF | 0.34 | N/A | N/A |
| Panoro Minerals Ltd. | |||
| CCMCF | 0.39 | N/A | N/A |
| Core Critical Metals Corp. | |||
| HNSPF | 4.90 | N/A | N/A |
| Hansoh Pharmaceutical Group Co Ltd. | |||